Pavan Reddy, M.D., Director, Senior Associate Dean of Cancer Programs, Dan L Duncan Comprehensive Cancer Center
There is nothing simple about establishing a legacy of integrity, excellence and belonging in the fourth-largest city in America, yet this is what the Dan L Duncan Comprehensive Cancer Center has achieved for all Houstonians suffering from cancer.
Over the past 20 years, the center has fostered scientific excellence by conducting groundbreaking transdisciplinary research that has revolutionized the way many cancers are diagnosed and treated. Our physicians provide comprehensive, compassionate, cutting-edge care to individuals from all walks of life — veterans, the indigent and uninsured, and children and adults from all over the world.
When I joined the DLDCCC at Baylor College of Medicine in 2022, I hosted numerous meetings with center members and the community to identify specific needs and goals.
With bi-directional input and enthusiastic support from institutional leaders, we developed six strategic pillars that form the foundation of the center’s basic, translational and clinical projects and themes. These pillars renew our focus on cancer equity and underpin the scientific and clinical programs that align with our strategic mission and values.
It is an honor to present the center’s strategic plan for the next five years, which builds on the groundbreaking research and patient-centered care championed by founding director Dr. Kent Osborne.
With this strategic plan, we will pioneer the next generation of innovative diagnostics and treatments while advancing novel strategies to prevent and eradicate cancer for all patients. By partnering cutting-edge science and clinical excellence with multidirectional engagement, we will pursue the ultimate goal of eradicating cancer from our community and beyond.
Sincerely,
Dr. Pavan Reddy
Director, Dan L Duncan Comprehensive Cancer Center
Helen E. Heslop, M.D., DSC (Hon)
Deputy Director, Dan L Duncan Comprehensive Cancer Center
Co-Leader of Cancer Cell & Gene Therapy Program
Donald Williams Parsons, M.D., Ph.D.
Pediatrician-in-Chief, Dan L Duncan Comprehensive Cancer Center
Benjamin Deneen, Ph.D.
Chair of the Dan L Duncan Comprehensive Cancer Center Research Committee
S. Gail Eckhardt
Associate Director of Translational Research, Dan L Duncan Comprehensive Cancer Center
Dean Edwards, Ph.D.
Associate Director of Shared Resources, Dan L Duncan Comprehensive Cancer Center
Suzanne A. W. Fuqua, Ph.D.
Co-Associate Director for Cancer Research Training and Education, Dan L Duncan Comprehensive Cancer Center
Co-Leader of Chromatin Biology Program
Peggy Goodell, Ph.D.
Associate Director for Basic Science, Dan L Duncan Comprehensive Cancer Center
Co-Leader, Cancer Cell and Gene Therapy Program, Dan L Duncan Comprehensive Cancer Center
Susan Hilsenbeck, Ph.D.
Director of Quantitative Science Shared Resource, Dan L Duncan Comprehensive Cancer Center
Chris Horaist
Associate Director for Administration, Dan L Duncan Comprehensive Cancer Center
Leo Luznik, M.D.
Physician-in-Chief, Dan L Duncan Comprehensive Cancer Center
Jason Mills, M.D., Ph.D.
Co-Associate Director for Cancer Research Training and Education, Dan L Duncan Comprehensive Cancer Center
Martha Mims, M.D., Ph.D.
Associate Director for Clinical Research, Dan L Duncan Comprehensive Cancer Center
Director, Clinical Trial Support Unit, Dan L Duncan Comprehensive Cancer Center
C. Kent Osborne, M.D.
Founding Director, Dan L Duncan Comprehensive Cancer Center
Ernest Ramsay Camp, M.D.
Surgeon-in-Chief, Dan L Duncan Comprehensive Cancer Center
Mothaffar F. Rimawi, M.D.
Associate Director of Clinical Affairs, Dan L Duncan Comprehensive Cancer Center
Rayne Rouce, M.D., B.S.
Associate Director for Community Outreach and Engagement, Dan L Duncan Comprehensive Cancer Center
Michael Scheurer, Ph.D., MPH
Associate Director for Inclusive Leadership and Culture, Dan L Duncan Comprehensive Cancer Center
Alastair Thompson, M.D.
Co-Leader for Breast Program, Dan L Duncan Comprehensive Cancer Center
Shawn Zhang, Ph.D.
Co-Leader for Breast Program, Dan L Duncan Comprehensive Cancer Center






